Ibrance (palbociclib) to treat advanced breast cancer

November 28, 2016- Interviewed by Steven E. Greer, MD We interviewed Richard Finn,

This entry was posted in - Biotech, - NEJM, - Pharma, Oncology, UCLA. Bookmark the permalink.

Leave a Reply

Your email address will not be published.